Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.
We are pleased to achieve this important milestone and remain vigilant as we work to continuously improve everything we do on behalf of the patients and providers we serve.” About Outset Medical, Inc.
Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...
EST Outset Medical (OM) files $100M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease from the previous $4.00, while continuing to recommend a Buy rating for the ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of ...
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
Outset Medical, Inc. has successfully closed a private placement, issuing 863,340 shares of Series A Non-Voting Convertible Preferred Stock and entered into a $100 million credit agreement with ...
Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM) 10-day simple moving average is 0.81. Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM ...
SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results